Degradation of MYCN oncoprotein by the ubiquitin system
- PMID: 1648744
Degradation of MYCN oncoprotein by the ubiquitin system
Abstract
Nuclear oncoproteins are among the most rapidly degraded intracellular proteins. Previous work has implicated the ubiquitin-mediated proteolytic system in the turnover of short-lived intracellular proteins as a class. In the present study, we have evaluated the potential role of the ubiquitin system in the degradation of the specific nuclear oncoproteins encoded by the MYCN gene. The oncoproteins were synthesized in vitro by transcription of an MYCN cDNA, and translation of the resulting single species of mRNA in the presence of 35S-methionine. Degradation of labeled proteins was monitored in a cell-free system derived from rabbit reticulocytes. ATP stimulated the degradation of the MYCN protein more than 10 fold. ATP-dependent degradation was completely inhibited by neutralizing antibody directed against E1, the first enzyme in the ubiquitin-mediated proteolytic cascade. Moreover, ATP-dependent degradation in E1-depleted lysate could be restored by the addition of affinity-purified E1. These data suggest that the ubiquitin system mediates the ATP-dependent degradation of MYCN oncoproteins in vitro, and that these proteins possess signals that target them for rapid turnover by this proteolytic pathway. Although MYCN in neuroblastomas is activated primarily by amplification, it may be activated by other mechanisms in aggressive tumors with a single copy of MYCN. Mutations in protein coding sequence that alter the signals for recognition by protein degradation systems represent a potential mechanism by which oncogene activation might occur.
Similar articles
-
Degradation of nuclear oncoproteins by the ubiquitin system in vitro.Proc Natl Acad Sci U S A. 1991 Jan 1;88(1):139-43. doi: 10.1073/pnas.88.1.139. Proc Natl Acad Sci U S A. 1991. PMID: 1846034 Free PMC article.
-
Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.Oncol Res. 1997;9(9):467-76. Oncol Res. 1997. PMID: 9495452
-
The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.Oncogene. 1991 Oct;6(10):1745-51. Oncogene. 1991. PMID: 1923500
-
Degradation of proteins by the ubiquitin-mediated proteolytic pathway.New Biol. 1990 Mar;2(3):227-34. New Biol. 1990. PMID: 2177651 Review.
-
The ubiquitin-mediated system for intracellular protein degradation.J Basic Clin Physiol Pharmacol. 1991 Jul-Sep;2(3):141-59. doi: 10.1515/jbcpp.1991.2.3.141. J Basic Clin Physiol Pharmacol. 1991. PMID: 1665707 Review.
Cited by
-
Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.RSC Chem Biol. 2020 Dec 1;1(5):305-332. doi: 10.1039/d0cb00111b. Epub 2020 Sep 16. RSC Chem Biol. 2020. PMID: 33791679 Free PMC article.
-
In silico modeling of phosphorylation dependent and independent c-Myc degradation.BMC Bioinformatics. 2019 May 8;20(1):230. doi: 10.1186/s12859-019-2846-x. BMC Bioinformatics. 2019. PMID: 31068129 Free PMC article.
-
The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.Nat Cell Biol. 2008 Jun;10(6):643-53. doi: 10.1038/ncb1727. Epub 2008 May 18. Nat Cell Biol. 2008. PMID: 18488021 Free PMC article.
-
The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects.Genes (Basel). 2017 Apr 5;8(4):116. doi: 10.3390/genes8040116. Genes (Basel). 2017. PMID: 28379189 Free PMC article. Review.
-
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.EMBO J. 2004 May 19;23(10):2116-25. doi: 10.1038/sj.emboj.7600217. Epub 2004 Apr 22. EMBO J. 2004. PMID: 15103331 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical